Literature DB >> 2581235

Tissue interactions and prostatic growth: II. Morphological and biochemical characterization of adult mouse prostatic hyperplasia induced by fetal urogenital sinus implants.

G J Miller, M N Runner, L W Chung.   

Abstract

Current hypotheses regarding the causes of human benign prostatic hyperplasia have implicated both steroid hormone imbalance and tissue interactions. To examine the role of the latter we have further investigated the phenomenon of urogenital sinus-induced hyperplasia of the adult mouse ventral prostate. Urogenital sinuses (UGS) or purified urogenital mesenchyme (UGM) from C3H mice were implanted into the ventral prostates or coagulating glands of 50- to 90-day-old BALB/c-nu/nu hosts. The animals were sacrificed at 15, 30, and 180 days postimplantation to establish time dependence. Wet weight and DNA content were used as measures of net growth. Glucose phosphate isomerase (GPI) isozyme analysis was used to determine the relative contributions of C3H and BALB/c cells to the enlarged chimeric ventral prostates. It was determined that the induced growth is time-dependent and that the UGS induces 2- to 4-fold more growth than UGM. GPI analysis shows that UGM-induced growth was composed primarily of host-derived cells whereas the UGS is composed nearly equally of host- and implant-derived cells. Histologic analysis reveals that the UGS implants induce marked epithelial proliferation. The proliferating glands occur in clusters, and the epithelium within the glands appears cribriform. Foci of postobstructive cystic atrophy are also found. Remnants of the implanted UGS are still present even at 180 days postimplantation. UGM-induced growth is of a more subtle nature and appears morphologically similar to the sham-operated controls. In view of the morphologic similarity with human disease, as well as the time and hormonal dependence of UGS-induced ventral prostatic hyperplasia, this model represents the basis for a unified hypothesis regarding the roles of tissue interaction and hormonal milieu in human benign prostatic hyperplasia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581235     DOI: 10.1002/pros.2990060304

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  3 in total

1.  Can stroma reaction predict cancer lethality?

Authors:  Michael R Freeman; Quanlin Li; Leland W K Chung
Journal:  Clin Cancer Res       Date:  2013-09-05       Impact factor: 12.531

Review 2.  Animal models of benign prostatic hyperplasia.

Authors:  Junjie Zhang; Mengda Zhang; Jin Tang; Guangming Yin; Zhi Long; Leye He; Chuanchi Zhou; Lufeng Luo; Lin Qi; Long Wang
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-09-01       Impact factor: 5.554

3.  Future perspectives of prostate cancer therapy.

Authors:  Murali Gururajan; Edwin M Posadas; Leland W K Chung
Journal:  Transl Androl Urol       Date:  2012-01-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.